Indivior Pharmaceuticals, Inc 6-K, filed Jul 10, 2023
Indivior Pharmaceuticals, Inc. (INDV)
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on July 10, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: July 10, 2023
Commission File Number: 001-37835
Indivior PLC
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
| Exhibit No. |
Description of Exhibit | |
| 99.1 | Announcement sent to the London Stock Exchange on July 10, 2023, titled “Holding(s) in Company”. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Indivior PLC | ||
| Date: July 10, 2023 | /s/ Kathryn Hudson | |
| Name: Kathryn Hudson | ||
| Title: Company Secretary | ||
Exhibit 99.1
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BN4HT335
Issuer Name
INDIVIOR PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments
3. Details of person subject to the notification obligation
Name
Morgan Stanley
City of registered office (if applicable)
Country of registered office (if applicable)
US
| Name |
City of registered office | Country of registered office | ||
| Morgan Stanley |
Wilmington, Delaware | USA |
4. Details of the shareholder
| Name |
City of registered office | Country of registered office | ||
| Morgan Stanley & Co. International plc |
London | UNITED KINGDOM |
5. Date on which the threshold was crossed or reached
05-Jul-2023
6. Date on which Issuer notified
07-Jul-2023
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|||||||||||||
| Resulting situation on the date on which threshold was crossed or reached |
4.224520 | 1.016987 | 5.241507 | 7226915 | ||||||||||||
| Position of previous notification (if applicable) |
3.247347 | 2.826248 | 6.073595 | |||||||||||||
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
||||||||||||
| GB00BN4HT335 |
5824708 | 4.224520 | ||||||||||||||
| Sub Total 8.A |
5824708 | 4.224520 | % | |||||||||||||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
||||||||||||
| Right of recall over securities lending agreements |
at any time | at any time | 745 | 0.000540 | ||||||||||||
|
|
|
|
|
|||||||||||||
| Sub Total 8.B1 |
745 | 0.000540 | % | |||||||||||||
|
|
|
|
|
|||||||||||||
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
|||||||||||||||
| Equity Swap |
07/09/2023 | at any time | Cash | 1401462 | 1.016447 | |||||||||||||||
|
|
|
|
|
|||||||||||||||||
| Sub Total 8.B2 |
1401462 | 1.016447 | % | |||||||||||||||||
|
|
|
|
|
|||||||||||||||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
| Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
||||||||||
| Morgan Stanley (Chain 1) |
||||||||||||||
| Morgan Stanley (Chain 1) |
Morgan Stanley International Holdings Inc. | |||||||||||||
| Morgan Stanley (Chain 1) |
Morgan Stanley International Limited | |||||||||||||
| Morgan Stanley (Chain 1) |
Morgan Stanley Investments (UK) | |||||||||||||
| Morgan Stanley (Chain 1) |
Morgan Stanley & Co. International plc | 4.224520 | 5.240966 | % | ||||||||||
| Morgan Stanley (Chain 2) |
||||||||||||||
| Morgan Stanley (Chain 2) |
Morgan Stanley Capital Management, LLC | |||||||||||||
| Morgan Stanley (Chain 2) |
Morgan Stanley Domestic Holdings, Inc. | |||||||||||||
| Morgan Stanley (Chain 2) |
Morgan Stanley & Co. LLC | |||||||||||||
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
07-Jul-2023
13. Place Of Completion
Mumbai